Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
[Plasmapheresis in central nervous system disorders].
Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetes Population: Analysis From DPV Data Base.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Rehabilitation interventions in multiple sclerosis: an overview.
Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
A genome screen for multiple sclerosis in Italian families.
Artielle Immunotherapeutics Announces Positive Results of Phase ! Multiple Sclerosis Trial
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
CHMP assessment report for Sovrima (International nonproprietary name: idebenone)
Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosis.
Moving towards the pan-European unification of Multiple Sclerosis Nurses: a consensus paper.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.
Long-term effects of dalfampridine in patients with multiple sclerosis.
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis.
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination.
Clinical overview of the seizure risk of dalfampridine.
"Undiagnosing" multiple sclerosis: The challenge of misdiagnosis in MS.
Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.

Pages